Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Oscar Health Inc (OSCR) vs Phillips 66 (PSX) Price & Performance

Oscar Health IncTrade
Phillips 66Trade

Price performance (Past 24H)

Key statistics

Oscar Health Inc vs Phillips 66 — how do they compare? Oscar Health Inc trades at $33.36 (market cap $10.22B), while Phillips 66 trades at $278 (market cap $112.36B). The key difference: Phillips 66 is far larger — about 11× Oscar Health Inc's market cap, and Phillips 66 pays a 1.8% dividend while Oscar Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Oscar Health Inc for 15 Days and Phillips 66 for 62 Days on average.

OSCRPSX
Market Cap
$10.22B$112.36B
Volume
4,123,3942,374,751
Sector
HealthEnergy
52-Week High
$33.81$281.60
52-Week Low
$10.85$126.76
Typical Hold Time
15 Days62 Days
Enterprise Value
$6.57B$128.83B
Dividend Yield
—1.8%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Oscar Health Inc

OSCR trades at $33.41, up 1.52% today, with a bullish technical signal and strong recent earnings beats in Q1 and Q2 2026. The stock shows robust revenue growth, with 2026 revenue projected at $15.3B and a return to profitability. Analyst sentiment is mixed but leans positive, with a consensus price target of $34.00. Recent news highlights market share gains and raised 2026 guidance, though the stock faces tests from rising medical costs.

The outlook is cautiously optimistic, driven by scalable growth in the ACA market and margin expansion opportunities. Key risks include medical cost pressures and competitive threats. Upside potential exists if the company executes on its 2029 EPS target of $4+, but investors should monitor profitability sustainability amid cost headwinds.

Phillips 66

Phillips 66 (PSX) trades at $283.31, up 4.3% with strong technical momentum and bullish moving average signals. The stock shows solid fundamentals with a P/E of 16.07, ROE of 24.02%, and consistent earnings beats in recent quarters. Recent news highlights structural refining advantages and AI implementation for operational efficiency, while analyst consensus remains positive with 54% buy ratings.

PSX presents a compelling investment case with strong profitability metrics and positive earnings momentum, though investors face risks from volatile energy markets and potential policy changes affecting diesel exports. The current price sits near consensus targets, suggesting balanced near-term upside potential with structural refining strengths supporting long-term value.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

OSCR

No sentiment data available yet.

PSX
100% Buy0% Sell
Avg holding period · 62 Days

About Oscar Health Inc

Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.

Read more on OSCR →

About Phillips 66

Phillips 66 is an independent refiner with 12 refineries that have a total crude throughput capacity of 2.0 million barrels per day, or mmb/d, after converting its 255 mb/d Alliance refinery to a terminal. The midstream segment comprises extensive transportation and NGL processing assets. It also includes its DCP Midstream joint venture, which holds 45 natural gas processing facilities, 11 NGL fractionation plants, and a natural gas pipeline system with 58,000 miles of pipeline. Its CPChem chemical joint venture operates facilities in the United States and the Middle East and primarily produces olefins and polyolefins.

Read more on PSX →